Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Osteoarthritis

Metabolomic characterization of metabolic phenotypes in OA

Increasing evidence implicates metabolic dysfunction in the development and progression of osteoarthritis (OA). Large-scale 'omics' studies, particularly metabolomics, have the potential to answer many questions relating to the pathogenesis of so-called 'metabolic OA' and other OA phenotypes, and could be key to the identification of novel biomarkers for these conditions.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Development of analytical platforms for OA biomarker discovery and validation.

References

  1. Adams, S. B. et al. Global metabolic profiling of human osteoarthritic synovium. Osteoarthritis Cartilage 20, 64–67 (2012).

    Article  Google Scholar 

  2. Ruiz-Romero, C. & Blanco, F. J. Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis. Osteoarthritis Cartilage 18, 500–509 (2010).

    Article  CAS  Google Scholar 

  3. Nicholson, J. K. & Wilson, I. D. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2, 668–676 (2003).

    Article  CAS  Google Scholar 

  4. Zhai, G. et al. Serum branched-chain amino acid to histidine ratio: a novel metabolomics biomarker of knee osteoarthritis. Ann. Rheum. Dis. 69, 1227–1231 (2010).

    Article  CAS  Google Scholar 

  5. Lamers, R. J. et al. Identification of an urinary metabolite profile associated with osteoarthritis. Osteoarthritis Cartilage 13, 762–768 (2005).

    Article  CAS  Google Scholar 

  6. Blanco, F. J., Rego, I. & Ruiz-Romero, C. The role of mitochondria in osteoarthritis. Nat. Rev. Rheumatol. 7, 161–169 (2011).

    Article  CAS  Google Scholar 

  7. Berenbaum, F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Ann. Rheum. Dis. 70, 1354–1356 (2011).

    Article  Google Scholar 

  8. Feder, J. et al. Parental diabetes status reveals association of mitochondrial DNA haplogroup J1 with type 2 diabetes. BMC Med. Genet. 10, 60 (2009).

    Article  Google Scholar 

  9. Niemi, A. K. et al. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum. Genet. 112, 29–33 (2003).

    Article  CAS  Google Scholar 

  10. Yang, T. L. et al. Genetic association study of common mitochondrial variants on body fat mass. PLoS ONE 6, e21595 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francisco J. Blanco.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blanco, F., Ruiz-Romero, C. Metabolomic characterization of metabolic phenotypes in OA. Nat Rev Rheumatol 8, 130–132 (2012). https://doi.org/10.1038/nrrheum.2012.11

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2012.11

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research